Related Experiment Video

Updated: Jun 2, 2026

Multiplex Immunohistochemical Analysis of the Spatial Immune Cell Landscape of the Tumor Microenvironment
06:32

Multiplex Immunohistochemical Analysis of the Spatial Immune Cell Landscape of the Tumor Microenvironment

Published on: August 18, 2023

Understanding the cross-talk between ovarian tumors and immune cells: mechanisms for effective immunotherapies

Maurizio Chiriva-Internati1, Leonardo Mirandola, W Martin Kast

  • 1Department of Internal Medicine at Division of Hematology/Oncology, Texas Tech University Health Sciences Center and Southwest Cancer Treatment and Research Center, Lubbock, Texas 79430, USA. maurizio.chiriva@ttuhsc.edu

International Reviews of Immunology
|May 12, 2011
PubMed

Insights

Ovarian cancer research shows the immune system can fight tumors, but the cancer creates barriers. Future immunotherapies must overcome these immune-inhibitory mechanisms for effective treatment.

Area of Science:

  • Oncology
  • Immunology

Background:

  • Ovarian cancer remains a significant cause of cancer-related deaths.
  • Emerging research highlights the immune system's role in controlling ovarian tumor progression.
  • Immunotherapy presents a promising therapeutic strategy for ovarian cancer.

Purpose of the Study:

  • To review the fundamental mechanisms of tumor immune surveillance in ovarian cancer.
  • To discuss advanced strategies for enhancing anti-tumor immune responses in ovarian cancer.

Main Methods:

  • Literature review of current research on ovarian cancer immunology.
  • Analysis of immune inhibitory mechanisms employed by ovarian tumors.
  • Evaluation of novel immunotherapy approaches.

Main Results:

  • Ovarian cancer actively suppresses anti-tumor immune responses.
  • Specific immune checkpoints and regulatory cells contribute to immune evasion.
  • Several cutting-edge strategies show potential to overcome these suppressive mechanisms.

Conclusions:

  • Understanding ovarian cancer's immune evasion tactics is crucial.
  • Developing immunotherapies that counteract immune suppression is key to improving patient outcomes.
  • Future research should focus on overcoming these obstacles for effective ovarian cancer treatment.

More Related Videos

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses10:35

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses

Published on: November 28, 2010

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...